Antibiotic Stewardship | Page 19 of 28 | Links Medicus Content Curation & Alerts in Medicine

Hot off the Press: Impact of Pharmacist-Led Antimicrobial
Stewardship on Appropriate Antibiotic Prescribing
in the Emergency Department: A Systematic
Review and Meta-Analysis https://t.co/NsZIubli8z pic.twitter.com/V2Sf6tLoKI

— AnnalsofEM (@AnnalsofEM) January 24, 2022

Special Issue: Evidence-based strategies for better antibiotic prescribing in primary care.

13 Feb, 2022 | 22:40h | UTC

Editorial: Antibiotic stewardship – Australian Journal of General Practice

Antibiotic stewardship: A review of successful, evidence-based primary care strategies – Australian Journal of General Practice

Evidence-based strategies for better antibiotic prescribing – Australian Journal of General Practice

How can general practitioners reduce antibiotic prescribing in collaboration with their patients? – Australian Journal of General Practice

RCT: Primary Norfloxacin prophylaxis prevents bacterial infections in patients with acute-on-chronic liver failure.

13 Feb, 2022 | 22:37h | UTC

Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial – The American Journal of Gastroenterology (link to abstract – $ for full-text)

Guideline for the management Herpes Simplex 1 and cosmetic interventions.

13 Feb, 2022 | 21:41h | UTC

Guideline for the Management Herpes Simplex 1 and Cosmetic Interventions – The Journal of Clinical and Aesthetic Dermatology

Guideline for the prevention, diagnosis, and management of acute bacterial soft tissue infections following nonsurgical cosmetic procedures.

13 Feb, 2022 | 21:40h | UTC

Guideline for the Prevention, Diagnosis, and Management of Acute Bacterial Soft Tissue Infections Following Nonsurgical Cosmetic Procedures – The Journal of Clinical and Aesthetic Dermatology

IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections.

11 Feb, 2022 | 08:51h | UTC

IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections – Clinical Microbiology and Infection

Original Guidelines:

European guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli.

IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.

Community control strategies for scabies: A cluster randomized trial showed one dose of Ivermectin was noninferior to two doses (7 to 14 days apart) to reduce the prevalence of the disease at 12 months.

11 Feb, 2022 | 08:38h | UTC

Community control strategies for scabies: A cluster randomised noninferiority trial – PLOS Medicine

News Release: One dose of anti-parasite drug just as effective as two at reducing scabies – Murdoch Children’s Research Institute

M-A: In patients undergoing transperineal prostate biopsy, there was no significant difference in infection, fever, sepsis or readmission rates with vs. without the use of prophylactic antibiotics.

11 Feb, 2022 | 08:16h | UTC

Infection Rate after Transperineal Prostate Biopsy with and without Prophylactic Antibiotics: Results from a Systematic Review and Meta-Analysis of Comparative Studies – Journal of Urology

European guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli.

9 Feb, 2022 | 10:18h | UTC

European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM –European Society of intensive care Medicine) – Clinical Microbiology and Infection

Australasian Consensus Guidelines for the use of antifungal agents in the hematology-oncology setting.

9 Feb, 2022 | 08:49h | UTC

Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021

Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021

Consensus guidelines for improving patients’ understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021

Randomized trial suggests it is safe to withhold antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria or preoperative indwelling catheter.

9 Feb, 2022 | 08:41h | UTC

Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial – The Journal of Urology (link to abstract – $ for full-text)

M-A: In women with preterm prelabor rupture of membranes, azithromycin is associated with lower rates of clinical chorioamnionitis compared to erythromycin.

8 Feb, 2022 | 08:37h | UTC

Erythromycin versus azithromycin for treatment of preterm prelabor rupture of membranes: A systematic review and meta-analysis – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)

Summary: 2021 CDC guidelines on sexually transmitted infections.

7 Feb, 2022 | 08:33h | UTC

2021 CDC guidelines on sexually transmitted infections – Family Medicine

Original Guideline: CDC releases new guidelines for the treatment of sexually transmitted infections.

A cohort study including 11 US hospitals and 232 patients with Vancomycin-resistant enterococci (VRE) showed an 18% mortality rate; failure of early eradication of VRE from the bloodstream was the strongest predictor of in-hospital mortality.

7 Feb, 2022 | 08:12h | UTC

Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I) – Open Forum Infectious Diseases

Commentary on Twitter

New in OFID: In a prospective cohort with enterococcal bloodstream infections, failure to eradicate vancomycin-resistant enterococci from the bloodstream early was a major factor associated with poor outcomes.

📄 https://t.co/I4hlelW2La @PaulSaxMD @DrJLi @FungalDoc @SuperBugDoc pic.twitter.com/m10YeVjUXw

— IDSA (@IDSAInfo) January 1, 2022